Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Journal of the Neurological Sciences - Netherlands
doi 10.1016/j.jns.2016.01.023
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis
Neurology
2011English

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

BMC Neurology
MedicineNeurology
2017English

Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Changes in Magnetic Resonance Imaging Disease Measures Over 3 Years in Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) Study

BMC Neurology
MedicineNeurology
2011English

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Journal of Negative Results in BioMedicine
GeneticsPharmacologyMolecular BiologyBiochemistryMedicineToxicologyPharmaceutics
2004English

Clinical Features, Diagnosis and Therapeutic Strategies in Pediatric Multiple Sclerosis

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2017English

Seasonal Adherence To, and Effectiveness Of, Subcutaneous Interferon Β-1a Administered by RebiSmart® in Patients With Relapsing Multiple Sclerosis: Results of the 1-Year, Observational GEPAT-SMART Study

BMC Neurology
MedicineNeurology
2018English

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

BMC Neurology
MedicineNeurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy